Novel adipokines and bone metabolism

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Liu, Yuan ^a   Song, Cheng Yuan ^b   Wu, Shan Shan ^a   Liang, Qiu Hua ^a   Yuan, Ling Qing ^a   Liao, Er Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CARBOXY TERMINAL TELOPEPTIDE; CHEMERIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; RESISTIN; UNCLASSIFIED DRUG; VASPIN;

ADIPOCYTE; ADIPOSE TISSUE; BONE DEVELOPMENT; BONE METABOLISM; BONE REGENERATION; BONE REMODELING; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CYTOKINE RELEASE; DRUG TARGETING; FRAGILITY FRACTURE; HUMAN; MORBIDITY; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

EID: 84874617151     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/895045     Document Type: Review

References (97)

1. Kim N., Kadono Y., Takami M., Lee J., Lee S. H., Okada F., Jung H. K., Kobayashi T., Odgren P. R., Nakano H., Yeh W. C., Lee S. K., Lorenzo J. A., Choi Y., Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. Journal of Experimental Medicine 2005 202 5 589 595 2-s2.0-24344433524 10.1084/jem.20050978 (Pubitemid 41248411)
2. Li Y., Li A., Strait K., Zhang H., Nanes M. S., Weitzmann M. N., Endogenous TNF α lowers maximum peak bone mass and inhibits osteoblastic smad activation through NF- B. Journal of Bone and Mineral Research 2007 22 5 646 655 2-s2.0-34447509873 10.1359/jbmr.070121 (Pubitemid 351339092)
3. Itoh S., Udagawa N., Takahashi N., Yoshitake F., Narita H., Ebisu S., Ishihara K., A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone 2006 39 3 505 512 2-s2.0-33746599062 10.1016/j.bone.2006.02.074 (Pubitemid 44149269)
4. Hyun W. L., Sang Y. K., Kim A. Y., Eun J. L., Choi J. Y., Jae B. K., Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells 2009 27 9 2254 2262 2-s2.0-70349974675 10.1002/stem.144
5. Yokota T., Reddy Meka C. S., Medina K. L., Igarashi H., Comp P. C., Takahashi M., Nishida M., Oritani K., Miyagawa J. I., Funahashi T., Tomiyama Y., Matsuzawa Y., Kincade P. W., Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. Journal of Clinical Investigation 2002 109 10 1303 1310 2-s2.0-0036105778 10.1172/JCI200214506 (Pubitemid 34546894)
6. Kanazawa I., Yamaguchi T., Yano S., Yamauchi M., Yamamoto M., Sugimoto T., Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biology 2007 8, article 51 2-s2.0-39349083877 10.1186/1471-2121-8-51
7. Huang C. Y., Lee C. Y., Chen M. Y., Tsai H. C., Hsu H. C., Tang C. H., Adiponectin increases BMP-2 expression in osteoblasts via AdipoR receptor signaling pathway. Journal of Cellular Physiology 2010 224 2 475 483 2-s2.0-77953644936 10.1002/jcp.22145
8. Oshima K., Nampei A., Matsuda M., Iwaki M., Fukuhara A., Hashimoto J., Yoshikawa H., Shimomura I., Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochemical and Biophysical Research Communications 2005 331 2 520 526 2-s2.0-18044394024 10.1016/j.bbrc.2005.03.210 (Pubitemid 40602668)
9. Yamaguchi N., Kukita T., Li Y. J., Martinez Argueta J. G., Saito T., Hanazawa S., Yamashita Y., Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. FEMS Immunology and Medical Microbiology 2007 49 1 28 34 2-s2.0-33846471601 10.1111/j.1574-695X.2006.00164.x (Pubitemid 46160583)
10. Luo E., Hu J., Bao C., Sustained release of adiponectin improves osteogenesis around hydroxyapatite implants by suppressing osteoclast activity in ovariectomized rabbits. Acta Biomaterialia 2012 8 2 734 743
11. Oh K. W., Lee W. Y., Rhee E. J., Baek K. H., Yoon K. H., Kang M. I., Yun E. J., Park C. Y., Ihm S. H., Choi M. G., Yoo H. J., Park S. W., The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clinical Endocrinology 2005 63 2 131 138 2-s2.0-23244450048 10.1111/j.1365-2265.2005.02312.x (Pubitemid 41097980)
12. Kontogianni M. D., Dafni U. G., Routsias J. G., Skopouli F. N., Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. Journal of Bone and Mineral Research 2004 19 4 546 551 2-s2.0-6344261900 10.1359/JBMR.040107 (Pubitemid 41071213)
13. Araneta M. R. G., Von Mühlen D., Barrett-Connor E., Sex differences in the association between adiponectin and BMD, bone loss, and fractures: the rancho bernardo study. Journal of Bone and Mineral Research 2009 24 12 2016 2022 2-s2.0-73849148427 10.1359/jbmr.090519
14. Komatsu J., Fujiwara M., Matsuura M., Ito S., Oritsu M., Study on the usefulness of high-molecular-weight (HMW)-Adiponectin level check of Japanese general population upon health check: comparison of carotid ultrasonography measurement. Clinical Biochemistry 2012 45 1-2 72 76
15. Imatoh T., Miyazaki M., Kadowaki K., Tanihara S., Akashi C., Une H., Measurement of high-molecular-weight adiponectin is not useful in assessing coronary stenosis. Clinical Chemistry and Laboratory Medicine 2012 50 4 741 745
16. Berner H. S., Lyngstadaas S. P., Spahr A., Monjo M., Thommesen L., Drevon C. A., Syversen U., Reseland J. E., Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004 35 4 842 849 2-s2.0-5344272498 10.1016/j.bone.2004.06.008 (Pubitemid 39349215)
17. Mödder U. I., Roforth M. M., Hoey K., McCready L. K., Peterson J. M., Monroe D. G., Oursler M. J., Khosla S., Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women. Bone 2011 49 2 202 207 2-s2.0-79958770416 10.1016/j.bone.2011.04.015
18. Thomas T., Gori F., Khosla S., Jensen M. D., Burguera B., Riggs B. L., Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999 140 4 1630 1638 2-s2.0-0032982438 (Pubitemid 29149231)
19. Xu J., Wu T., Zhong Z., Zhao C., Tang Y., Chen J., Effect and mechanism of leptin on osteoblastic differentiation of hBMSCs. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2009 23 2 140 144 2-s2.0-66449131622
20. Um S., Choi J. R., Lee J. H., Zhang Q., Seo B., Effect of leptin on differentiation of human dental stem cells. Oral Diseases 2011 17 7 662 669
21. Holloway W. R., Collier F. M. L., Aitken C. J., Myers D. E., Hodge J. M., Malakellis M., Gough T. J., Collier G. R., Nicholson G. C., Leptin inhibits osteoclast generation. Journal of Bone and Mineral Research 2002 17 2 200 209 2-s2.0-0036150527 (Pubitemid 34087652)
22. Ogueh O., Sooranna S., Nicolaides K. H., Johnson M. R., The relationship between leptin concentration and bone metabolism in the human fetus. Journal of Clinical Endocrinology and Metabolism 2000 85 5 1997 1999 2-s2.0-0034458070 10.1210/jc.85.5.1997 (Pubitemid 32269311)
23. Cornish J., Callon K. E., Bava U., Lin C., Naot D., Hill B. L., Grey A. B., Broom N., Myers D. E., Nicholson G. C., Reid I. R., Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. Journal of Endocrinology 2002 175 2 405 415 2-s2.0-18744376564 10.1677/joe.0.1750405 (Pubitemid 35414387)
24. Wang L., Yuan J. S., Zhang H. X., Ding H., Tang X. G., Wei Y. Z., Effect of leptin on bone metabolism in rat model of traumatic brain injury and femoral fracture. Chinese Journal of Traumatology 2011 14 1 7 13 2-s2.0-79952778170 10.3760/cma.j.issn.1008-1275.2011.01.002
25. Wang L., Tang X., Zhang H., Yuan J., Ding H., Wei Y., Elevated leptin expression in rat model of traumatic spinal cord injury and femoral fracture. Journal of Spinal Cord Medicine 2011 34 5 501 509
26. van der Velde M., van der Eerden B. C., Sun Y., An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects. Endocrinology 2012 153 8 3593 3602
27. Bertoni L., Ferretti M., Cavani F., Zavatti M., Resca E., Benelli A., Palumbo C., Leptin increases growth of primary ossification centers in fetal mice. Journal of Anatomy 2009 215 5 577 583
28. Turner R. T., Kalra S. P., Wong C. P., Philbrick K. A., Lindenmaier L. B., Boghossian S., Iwaniec U. T., Peripheral leptin regulates bone formation. Journal of Bone and Mineral Research 2013 28 1 22 34
29. Hamrick M. W., Della-Fera M. A., Choi Y. H., Pennington C., Hartzell D., Baile C. A., Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. Journal of Bone and Mineral Research 2005 20 6 994 1001 2-s2.0-19044381754 10.1359/JBMR.050103 (Pubitemid 40712824)
30. Bartell S. M., Rayalam S., Ambati S., Gaddam D. R., Hartzell D. L., Hamrick M., She J. X., Della-Fera M. A., Baile C. A., Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice. Journal of Bone and Mineral Research 2011 26 8 1710 1720 2-s2.0-79960629585 10.1002/jbmr.406
31. Ducy P., Amling M., Takeda S., Priemel M., Schilling A. F., Beil F. T., Shen J., Vinson C., Rueger J. M., Karsenty G., Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000 100 2 197 207 2-s2.0-0141737573 (Pubitemid 30064908)
32. Yadav V. K., Oury F., Suda N., Liu Z. W., Gao X. B., Confavreux C., Klemenhagen K. C., Tanaka K. F., Gingrich J. A., Guo X. E., Tecott L. H., Mann J. J., Hen R., Horvath T. L., Karsenty G., A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 2009 138 5 976 989 2-s2.0-69449083603 10.1016/j.cell.2009.06.051
33. Elefteriou F., Ahn J. D., Takeda S., Starbuck M., Yang X., Liu X., Kondo H., Richards W. G., Bannon T. W., Noda M., Clement K., Valsse C., Karsenty G., Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005 434 7032 514 520 2-s2.0-15844384047 10.1038/nature03398 (Pubitemid 40477060)
34. Barbour K. E., Zmuda J. M., Boudreau R., The effects of adiponectin and leptin on changes in bone mineral density. Osteoporosis International 2012 23 6 1699 1710
35. Sherk V. D., Malone S. P., Bemben M. G., Knehans A. W., Palmer I. J., Bemben D. A., Leptin, fat mass, and bone mineral density in healthy pre- and postmenopausal women. Journal of Clinical Densitometry 2011 14 3 321 325 2-s2.0-79960918937 10.1016/j.jocd.2011.03.010
36. Koroglu B. K., Kiris F., Ersoy I. H., Sutcu R., Yildiz M., Aksu O., Ermis F., Ersoy S., Tamer M. N., Relation of leptin, adiponectin and insulin resistance to bone mineral density in type 2 diabetic postmenopausal women. Endokrynologia Polska 2011 62 5 429 435
37. Iida T., Domoto T., Takigawa A., Nakamura S., Kato Y., Togo M., Chikamura C., Harada T., Ishizaki F., Ono Y., Relationships among blood leptin and adiponectin levels, fat mass, and bone mineral density in Japanese pre- and postmenopausal women. Hiroshima Journal of Medical 2011 60 4 71 78
38. Zhang H., Xie H., Zhao Q., Xie G. Q., Wu X. P., Liao E. Y., Luo X. H., Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women. Journal of Endocrinological Investigation 2010 33 10 707 711 2-s2.0-77954338033 10.3275/6886
39. Wu N., Wang Q. P., Li H., Wu X. P., Sun Z. Q., Luo X. H., Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women. Clinica Chimica Acta 2010 411 9-10 771 775 2-s2.0-77950461766 10.1016/j.cca.2010.02.064
40. Rhie Y. J., Lee K. H., Chung S. C., Kim H. S., Kim D. H., Effects of body composition, leptin, and adiponectin on bone mineral density in prepubertal girls. Journal of Korean Medical Science 2010 25 8 1187 1190 2-s2.0-77956583395 10.3346/jkms.2010.25.8.1187
41. King G. A., Deemer S. E., Thompson D. L., Relationship between leptin, adiponectin, bone mineral density, and measures of adiposity among pre-menopausal hispanic and caucasian women. Endocrine Research 2010 35 3 106 117 2-s2.0-77955684261 10.3109/07435800.2010.496090
42. Yilmaz A., Nur N., Turgut B., Leptin and bone mineral density in haemodialysis patients. Annals of the Academy of Medicine Singapore 2009 38 4 374 377 2-s2.0-65749087038
43. Yang L. C., Lan Y., Hu J., Yang Y. H., Zhang Q., Piao J. H., Correlation of serum leptin level with bone mineral density and bone turnover markers in Chinese adolescent dancers. Biomedical and Environmental Sciences 2009 22 5 369 373 2-s2.0-74349105036 10.1016/S0895-3988(10)60013-X
44. Oguz S., Tapisiz O. L., Aytan H., Gunyeli I., Erdem S., Tuncay G., Bilge U., Mollamahmutoglu L., Is leptin a significant predictor of bone mineral density in postmenopausal Turkish women? Rheumatology International 2009 29 4 393 396 2-s2.0-59449107424 10.1007/s00296-008-0711-8
45. Lei X., Peng X., Wu N., Hu M., Sun Z., Serum adiponectin, leptin level, and bone mineral density in postmenopausal women. Zhong Nan da Xue Xue Bao 2009 34 6 559 562 2-s2.0-68149176710
46. Yang L. F., Xie H., Yuan L. Q., Wu X. P., Serum adiponectin and leptin levels and bone mineral density in 232 men. Journal of Central South University 2008 33 6 523 526 2-s2.0-47549109248
47. Tamura T., Yoneda M., Yamane K., Nakanishi S., Nakashima R., Okubo M., Kohno N., Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus. Metabolism 2007 56 5 623 628 2-s2.0-34147184714 10.1016/j.metabol.2006.12.008 (Pubitemid 46574724)
48. Jiang Y. X., Tang S. Y., Wu X. P., Yang L. F., Liao E. Y., Serum leptin with bone mineral density and body fat mass in males. Journal of Central South University 2007 32 6 1075 1079 2-s2.0-38649130499
49. Di Carlo C., Tommaselli G. A., Di Spiezio Sardo A., Sammartino A., Attianese W., Gargano V., Bifulco G., Nappi C., Longitudinal evaluation of serum leptin and bone mineral density in early postmenopausal women. Menopause 2007 14 3 450 454 2-s2.0-34447293999 10.1097/01.gme.0000236936.28454.6a
50. Peng X. D., Xie H., Zhao Q., Wu X. P., Sun Z. Q., Liao E. Y., Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clinica Chimica Acta 2008 387 1-2 31 35 2-s2.0-35748976865 10.1016/j.cca.2007.08.012 (Pubitemid 350050925)
51. Tohidi M., Akbarzadeh S., Larijani B., Kalantarhormozi M., Ostovar A., Assadi M., Vahdat K., Farrokhnia M., Sanjdideh Z., Amirinejad R., Nabipour I., Omentin-1, visfatin and adiponectin levels in relation to bone mineral density in Iranian postmenopausal women. Bone 2012 51 5 876 881
52. Iacobellis G., Iorio M., Napoli N., Cotesta D., Zinnamosca L., Marinelli C., Petramala L., Minisola S., D'Erasmo E., Letizia C., Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome. Journal of Endocrinological Investigation 2011 34 1 e12 15 2-s2.0-79959786213
53. Anastasilakis A. D., Polyzos S. A., Delaroudis S., Bisbinas I., Sakellariou G. T., Gkiomisi A., Papadopoulou E., Gerou S., Makras P., The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass. Clinical Endocrinology 2012 77 6 816 822 10.1111/j.1365-2265.2012.04459.x
54. Koiou E., Tziomalos K., Dinas K., The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocrine Journal 2011 58 4 237 246
55. Phalitakul S., Okada M., Hara Y., Yamawaki H., Vaspin prevents TNF-alpha-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-kappaB and PKCtheta activation in cultured rat vascular smooth muscle cells. Pharmacological Research 2011 64 5 493 500
56. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S., Lazar M. A., The hormone resistin links obesity to diabetes. Nature 2001 409 6818 307 312 2-s2.0-0035905758 10.1038/35053000 (Pubitemid 32151228)
57. Aust G., Richter O., Rohm S., Kerner C., Hauss J., Klöting N., Ruschke K., Kovacs P., Youn B. S., Blüher M., Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 2009 204 1 262 266 2-s2.0-67349205552 10.1016/j.atherosclerosis.2008.08.028
58. Scherer P. E., Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006 55 6 1537 1545 2-s2.0-33747356154 10.2337/db06-0263 (Pubitemid 44324105)
59. Challa T. D., Rais Y., Ornan E. M., Effect of adiponectin on ATDC5 proliferation, differentiation and signaling pathways. Molecular and Cellular Endocrinology 2010 323 2 282 291 2-s2.0-77952957668 10.1016/j.mce.2010.03.025
60. Lenchik L., Register T. C., Hsu F. C., Lohman K., Nicklas B. J., Freedman B. I., Langefeld C. D., Carr J. J., Bowden D. W., Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003 33 4 646 651 2-s2.0-0141638664 10.1016/S8756-3282(03)00237-0 (Pubitemid 37222391)
61. Jürimäe J., Rembel K., Jürimäe T., Rehand M., Adiponectin is associated with bone mineral density in perimenopausal women. Hormone and Metabolic Research 2005 37 5 297 302 2-s2.0-21244505055 10.1055/s-2005-861483 (Pubitemid 40896213)
62. Özkurt B., Özkurt Z. N., Altay M., Aktekin C. N., Çalayan O., Tabak Y., The relationship between serum adiponectin level and anthropometry, bone mass, osteoporotic fracture risk in postmenopausal women. Eklem Hastaliklari ve Cerrahisi 2009 20 2 78 84 2-s2.0-70349242268
63. Sodi R., Hazell M. J., Durham B. H., Rees C., Ranganath L. R., Fraser W. D., The circulating concentration and ratio of total and high molecular weight adiponectin in post-menopausal women with and without osteoporosis and its association with body mass index and biochemical markers of bone metabolism. Clinical Biochemistry 2009 42 13-14 1375 1380 2-s2.0-69249213476 10.1016/j.clinbiochem.2009.06.003
64. Basurto L., Galván R., Cordova N., Saucedo R., Vargas C., Campos S., Halley E., Avelar F., Zárate A., Adiponectin is associated with low bone mineral density in elderly men. European Journal of Endocrinology 2009 160 2 289 293 2-s2.0-61449094767 10.1530/EJE-08-0569
65. Richards J. B., Valdes A. M., Burling K., Perks U. C., Spector T. D., Serum adiponectin and bone mineral density in women. Journal of Clinical Endocrinology and Metabolism 2007 92 4 1517 1523 2-s2.0-34147184458 10.1210/jc.2006-2097 (Pubitemid 46556433)
66. Jürimäe J., Jürimäe T., Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. American Journal of Physiology 2007 293 1 E42 E47 2-s2.0-34547123090 10.1152/ajpendo.00610.2006 (Pubitemid 47105914)
67. Zoico E., Zamboni M., Di Francesco V., Mazzali G., Fantin F., De Pergola G., Zivelonghi A., Adami S., Bosello O., Relation between adiponectin and bone mineral density in elderly post-menopausal women: role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate. Journal of Endocrinological Investigation 2008 31 4 297 302 2-s2.0-44849139797 (Pubitemid 351796614)
68. Biver E., Salliot C., Combescure C., Gossec L., Hardouin P., Legroux-Gerot I., Cortet B., Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. Journal of Clinical Endocrinology & Metabolism 2011 96 9 2703 2713
69. Abaht K., Gürlek A., Karakaya J., Bayraktar M., Circulating adiponectin represents a biomarker of the association between adiposity and bone mineral density. Endocrine 2009 35 3 371 379 2-s2.0-70149087706 10.1007/s12020-009-9158-2
70. Jürimäe J., Kums T., Jürimäe T., Adipocytokine and ghrelin levels in relation to bone mineral density in physically active older women: longitudinal associations. European Journal of Endocrinology 2009 160 3 381 385 2-s2.0-62649091301 10.1530/EJE-08-0673
71. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Yano S., Sugimoto T., Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. European Journal of Endocrinology 2009 160 2 265 273 2-s2.0-61449206180 10.1530/EJE-08-0642
72. Filip R., Raszewski G., Bone mineral density and bone turnover in relation to serum leptin, α -ketoglutarate and sex steroids in overweight and obese postmenopausal women. Clinical Endocrinology 2009 70 2 214 220 2-s2.0-58549107572 10.1111/j.1365-2265.2008.03313.x
73. Do Prado W. L., De Piano A., Lazaretti-Castro M., De Mello M. T., Stella S. G., Tufik S., Do Nascimento C. M. O., Oyama L. M., Lofrano M. C., Tock L., Caranti D. A., Dâmaso A. R., Relationship between bone mineral density, leptin and insulin concentration in Brazilian obese adolescents. Journal of Bone and Mineral Metabolism 2009 27 5 613 619 2-s2.0-68949148538 10.1007/s00774-009-0082-6
74. Patel L., Buckels A. C., Kinghorn I. J., Murdock P. R., Holbrook J. D., Plumpton C., Macphee C. H., Smith S. A., Resistin is expressed in human macrophages and directly regulated by PPAR γ activators. Biochemical and Biophysical Research Communications 2003 300 2 472 476 2-s2.0-0037427540 10.1016/S0006-291X(02)02841-3 (Pubitemid 38375833)
75. Thommesen L., Stunes A. K., Monjo M., Grosvik K., Tamburstuen M. V., Kjobli E., Lyngstadaas S. P., Reseland J. E., Syversen U., Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. Journal of Cellular Biochemistry 2006 99 3 824 834 (Pubitemid 44522000)
76. Krzysik-Walker S. M., Hadley J. A., Pesall J. E., McFarland D. C., Vasilatos-Younken R., Ramachandran R., Nampt/visfatin/PBEF affects expression of myogenic regulatory factors and is regulated by interleukin-6 in chicken skeletal muscle cells. Comparative Biochemistry and Physiology 2011 159 4 413 421 2-s2.0-79957604613 10.1016/j.cbpa.2011.04.007
77. Xie H., Tang S. Y., Luo X. H., Huang J., Cui R. R., Yuan L. Q., Zhou H. D., Wu X. P., Liao E. Y., Insulin-like effects of visfatin on human osteoblasts. Calcified Tissue International 2007 80 3 201 210 2-s2.0-33947150636 10.1007/s00223-006-0155-7 (Pubitemid 46411878)
78. Li Y., He X., He J., Anderstam B., Andersson G., Lindgren U., Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: a possible cause for reduced osteogenesis and increased adipogenesis in older individuals. Journal of Bone and Mineral Research 2011 26 11 2656 2664
79. Moschen A. R., Geiger S., Gerner R., Tilg H., Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease. Mutation Research 2010 690 1-2 95 101 2-s2.0-77955282709 10.1016/j.mrfmmm.2009. 06.012
80. Cekmez F., Canpolat F. E., Pirgon O., Cetinkaya M., Aydinoz S., Suleymanoglu S., Ipcioglu O. M., Sarici S. U., Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance. Cytokine 2011 56 2 387 391
81. Kukla M., Mazur W., Buldak R. J., Zwirska-Korczala K., Potential role of leptin, adiponectin and three novel adipokines-visfatin, chemerin and vaspin-in chronic hepatitis. Molecular Medicine 2011 17 11-12 1397 1410
82. Zhu X., Jiang Y., Shan P. F., Shen J., Liang Q. H., Cui R. R., Liu Y., Liu G. Y., Wu S. S., Lu Q., Xie H., Liu Y. S., Yuan L. Q., Liao E. Y., Vaspin attenuates the apoptosis of human osteoblasts through ERK signaling pathway. Amino Acids. In press
83. Muruganandan S., Roman A. A., Sinal C. J., Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. Journal of Bone and Mineral Research 2010 25 2 222 234 2-s2.0-77953441290 10.1359/jbmr.091106
84. Assadi M., Salimipour H., Akbarzadeh S., Nemati R., Jafari S. M., Bargahi A., Samani Z., Seyedabadi M., Sanjdideh Z., Nabipour I., Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue. PLoS ONE 2011 6 9 e24240
85. Shibata R., Ouchi N., Takahashi R., Terakura Y., Ohashi K., Ikeda N., Higuchi A., Terasaki H., Kihara S., Murohara T., Omentin as a novel biomarker of metabolic risk factors. Diabetology & Metabolic Syndrome 2012 4 1 37
86. Xie H., Xie P. L., Luo X. H., Wu X. P., Zhou H. D., Tang S. Y., Liao E. Y., Omentin-1 exerts bone-sparing effect in ovariectomized mice. Osteoporosis International 2012 23 4 1425 1436
87. Guo L. J., Jiang T. J., Liao L., Liu H., He H. B., Relationship between serum omentin-1 level and bone mineral density in girls with anorexia nervosa. Journal of Endocrinological Investigation. In press
88. Holroyd C., Cooper C., Dennison E., Epidemiology of osteoporosis. Best Practice and Research 2008 22 5 671 685 2-s2.0-56349147387 10.1016/j.beem.2008. 06.001
89. Henry M. J., Pasco J. A., Nicholson G. C., Kotowicz M. A., Prevalence of osteoporosis in Australian men and women: Geelong Osteoporosis Study. Medical Journal of Australia 2011 195 6 321 322
90. Tuzun S., Eskiyurt N., Akarirmak U., Saridogan M., Senocak M., Johansson H., Kanis J. A., Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study. Osteoporosis International 2012 23 3 949 955 2-s2.0-79955945241 10.1007/s00198-011-1655-5
91. Liao E. Y., Wu X. P., Deng X. G., Huang G., Zhu X. P., Long Z. F., Wang W. B., Tang W. L., Zhang H., Age-related bone mineral density, accumulated bone loss rate and prevalence of osteoporosis at multiple skeletal sites in Chinese women. Osteoporosis International 2002 13 8 669 676 2-s2.0-0036345913 10.1007/s001980200091
92. Moore A. E., Blake G. M., Taylor K. A., Ruff V. A., Rana A. E., Wan X., Fogelman I., Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis. European Journal of Nuclear Medicine and Molecular Imaging 2012 39 2 326 336
93. Walsh J. B., Lems W. F., Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS). Calcified Tissue International 2012 90 5 373 383
94. Yu S., Burge R. T., Foster S. A., Gelwicks S., Meadows E. S., The impact of teriparatide adherence and persistence on fracture outcomes. Osteoporosis International 2012 23 3 1103 1113
95. Christenson E. S., Jiang X., Kagan R., Schnatz P., Osteoporosis management in post-menopausal women. Minerva Ginecologica 2012 64 3 181 194
96. Iki M., Epidemiology of osteoporosis in Japan. Clinical Calcium 2012 22 6 797 803
97. Lippuner K., Epidemiology and burden of osteoporosis in Switzerland. Therapeutische Umschau 2012 69 3 137 144